GW&K Investment Management LLC boosted its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 1,169,047.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 198,755 shares of the company's stock after purchasing an additional 198,738 shares during the quarter. GW&K Investment Management LLC owned 0.38% of Molina Healthcare worth $37,585,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Private Wealth Asset Management LLC bought a new position in Molina Healthcare during the 3rd quarter worth $1,078,000. Private Advisor Group LLC acquired a new position in Molina Healthcare in the third quarter valued at about $264,000. Focus Advisor Solutions LLC raised its stake in Molina Healthcare by 93.8% in the third quarter. Focus Advisor Solutions LLC now owns 20,985 shares of the company's stock valued at $3,968,000 after purchasing an additional 10,156 shares in the last quarter. Voya Investment Management LLC lifted its position in Molina Healthcare by 138.4% during the third quarter. Voya Investment Management LLC now owns 27,094 shares of the company's stock worth $5,123,000 after purchasing an additional 15,729 shares during the period. Finally, Global Retirement Partners LLC increased its holdings in Molina Healthcare by 30.4% in the 3rd quarter. Global Retirement Partners LLC now owns 223 shares of the company's stock valued at $42,000 after buying an additional 52 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on MOH shares. Weiss Ratings raised Molina Healthcare from a "sell (d)" rating to a "sell (d+)" rating in a report on Wednesday, October 21st. Truist Financial reduced their price target on Molina Healthcare from $250.00 to $225.00 and set a "hold" rating on the stock in a research report on Friday, July 24th. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Molina Healthcare in a research note on Tuesday, October 27th. UBS Group boosted their target price on Molina Healthcare from $202.00 to $225.00 and gave the company a "neutral" rating in a research report on Friday, October 23rd. Finally, Morgan Stanley boosted their target price on shares of Molina Healthcare from $167.00 to $192.00 and gave the stock an "equal weight" rating in a research report on Friday, October 23rd. Three analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $213.88.
Check Out Our Latest Report on Molina Healthcare
Insider Activity at Molina Healthcare
In other news, Director Steven Orlando sold 702 shares of the company's stock in a transaction on Monday, November 16th. The shares were sold at an average price of $227.33, for a total value of $159,585.66. Following the completion of the sale, the director owned 17,569 shares of the company's stock, valued at approximately $3,993,960.77. This represents a 3.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Dale Wolf sold 1,600 shares of the stock in a transaction that occurred on Friday, November 13th. The shares were sold at an average price of $206.12, for a total value of $329,792.00. Following the sale, the director directly owned 14,337 shares of the company's stock, valued at approximately $2,955,142.44. This trade represents a 10.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 11,084 shares of company stock valued at $2,273,419. 1.44% of the stock is currently owned by insiders.
Molina Healthcare Price Performance
Shares of NYSE:MOH opened at $198.66 on Friday. The firm has a market capitalization of $10.37 billion, a PE ratio of -206.94, a P/E/G ratio of 13.74 and a beta of 0.75. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.95. The company has a 50-day moving average price of $203.94 and a two-hundred day moving average price of $186.45. Molina Healthcare, Inc has a twelve month low of $121.06 and a twelve month high of $244.89.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The company had revenue of $11.08 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same period in the previous year, the business earned $1.84 earnings per share. The firm's quarterly revenue was down 3.4% compared to the same quarter last year. Equities analysts forecast that Molina Healthcare, Inc will post 5.30 EPS for the current year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.